Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 28, 2013; 19(32): 5377-5380
Published online Aug 28, 2013. doi: 10.3748/wjg.v19.i32.5377
Published online Aug 28, 2013. doi: 10.3748/wjg.v19.i32.5377
4-wkfollow up | 8-wkfollow up | 12-wkfollow up | |
FEV1, L | 2.03 (58%) | 2.24 (64%) | 2.56 (73%) |
FVC, L | 2.08 (52%) | 2.33 (58%) | 2.62 (66%) |
TLC, L | 3.04 (56%) | 3.63 (67%) | 3.73 (69%) |
RV, L | 0.91 (62%) | 1.30 (88%) | 0.97 (66%) |
FRC, L | 1.62 (57%) | 2.47 (87%) | 2.44 (86%) |
DLCO, mL/mmHg per minute | NA | 17.3 (58%) | 19.0 (64%) |
- Citation: Caccaro R, Savarino E, D’Incà R, Sturniolo GC. Noninfectious interstitial lung disease during infliximab therapy: Case report and literature review. World J Gastroenterol 2013; 19(32): 5377-5380
- URL: https://www.wjgnet.com/1007-9327/full/v19/i32/5377.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i32.5377